Therapeutic efficacy of salvage hyperbaric oxygen therapy in sudden sensorineural hearing loss after failure of steroids

Yıl 2017, Cilt: 7 Sayı: 3, 120 - 125, 28.11.2017

Abdulkadir İmre İbrahim Aladağ Ercan Pınar Hale Aslan Rıdvan Duran Mustafa Yazır

Öz

Objective: The aim of this study was to
evaluate the efficacy of hyperbaric oxygen (HBO) therapy as salvage
therapy in patients with idiopathic sudden sensorineural hearing loss
(ISSNHL) after failure of systemic therapy.




Methods:
Forty-eight consecutive patients with refractory ISSNHL were enrolled
retrospectively. All patients were given systemic steroid therapy by
tapered doses. In addition, forty-one patients received intratympanic
dexamethasone injection. Hearing outcomes were determined by recovery
rate according to Siegel's criteria and hearing gains in pure-tone
average (PTA) measured by audiometry before and after HBO therapy. The
effects of prognostic factors on hearing recovery were also evaluated.





Results:
Thirteen (27%) patients responded to HBO therapy. The remaining 35 (73%)
patients did not show any improvement. After HBO therapy, significant
improvement was found in mean hearing thresholds at all frequencies.
Only the level of initial PTA level and gender were significantly
associated with recovery. Patients with severe hearing loss (≥70 dB) had
significantly better results.




Conclusion:
Salvage HBO therapy may be beneficial in patients with ISSNHL who failed
to recover by primary combined steroid therapy. Further hearing
recovery with salvage HBO therapy can be expected, particularly in
patients with PTA greater than 70 dB.

Anahtar Kelimeler

Hyperbaric oxygen therapy, idiopathic sensorineural hearing loss, salvage therapy

Kaynakça

• Fetterman BL, Saunders JE, Luxford WM. Prognosis and treat- ment of sudden sensorineural hearing loss. Am J Otol 1996;17: 529–36. 2. Mattox DE, Simmons FB. Natural history of sudden sensorineur- al hearing loss. Ann Otol Rhinol Laryngol 1977;86:463–80. 3. Rauch SD. Clinical practice: idiopathic sudden sensorineural hear- ing loss. N Engl J Med 2008;359:833–40. 4. Li P, Zeng XL, Ye J, Yang QT, Zhang GH, Li Y. Intratympanic methylprednisolone improves hearing function in refractory sud- den sensorineural hearing loss: a control study. Audiol Neurootol 2011;16:198–202. 5. Stachler RJ, Chandrasekhar SS, Archer SM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 2012;146(Suppl 3):S1–S35. 6. Gundogan O, Pinar E, Imre A, Ozturkcan S, Cokmez O, Yigiter AC. Therapeutic efficacy of the combination of intratympanic methylprednisolone and oral steroid for idiopathic sudden deaf- ness. Otolaryngol Head Neck Surg 2013;149:753–8. 7. Battaglia A, Lualhati A, Lin H, Burchette R, Cueva R. A prospec- tive, multi-centered study of the treatment of idiopathic sudden sensorineural hearing loss with combination therapy versus high- dose predisone alone: a 139 patient follow-up. Otol Neurotol 2014;35:1091–8. 8. Koltsidopoulos P, Bibas A, Sismanis A, Tzonou A, Seggas I. Intratympanic and systemic steroids for sudden hearing loss. Otol Neurotol 2013;34:771–6. 9. Hosokawa S, Sugiyama KI, Takahashi G, et al. Hyperbaric oxygen therapy as adjuvant treatment for idiopathic sudden sensorineural hearing loss after failure of systemic steroids. Audiol Neurootol 2017;22:9–14. 10. Yang CH, Wu RW, Hwang CF. Comparison of intratympanic steroid injection, hyperbaric oxygen and combination therapy in refractory sudden sensorineural hearing loss. Otol Neurotol 2013; 34:1411–6. 11. Nagahara K, Fisch U, Yagi N. Perilymph oxygenation in sudden and progressive sensorineural hearing loss. Acta Otolaryngol 1983; 96:57–68. 12. Bennet MH, Kertesz T, Yeung P, Lehm JP. Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. Cochrane Database Syst Rev 2012:10;CD004739. 13. Cvorovic L, Jovanovic MB, Milutinovic Z, Arsovic N, Djeric D. Randomized prospective trial of hyperbaric oxygen therapy and intratympanic steroid injection as salvage treatment of sudden sen- sorineural hearing loss. Otol Neurotol 2013;34:1021–6. 14. Pezzoli M, Magnano M, Maffi L, et al. Hyperbaric oxygen thera- py as salvage treatment for sudden sensorineural hearing loss: a prospective controlled study. Eur Arch Otorhinolaryngol 2015;272:1659–66. 15. Alimoglu Y, Inci E. Is hyperbaric oxygen therapy a salvage treat- ment option for sudden sensorineural hearing loss? J Otol Laryngol 2016;130:943–7. 16. Desloovere C, Knecht R, Germonpre P. Hyperbaric oxygen ther- apy after failure of conventional therapy for sudden deafness. B- ENT 2006;2:69–73. 17. Ohno K, Noguchi Y, Kawashima Y, Yagishita K, Kitamura K. Secondary hyberbaric oxygen therapy for idiopathic sudden sen- sorineural hearing loss in subacute and chronic phases. J Med Dent Sci 2010;57:127–32. 18. Korpinar S, Alkan Z, Yigit O, et al. Factors influencing the out- come of idiopathic sudden sensorineural hearing loss treated with hyperbaric oxygen therapy. Eur Arch Otorhinolaryngol 2011;268: 41–7. 19. Suzuki H, Hashida K, Nguyen KH, et al. Efficacy of intratympanic steroid administration on idiopathic sudden sensorineural hearing loss in comparison with hyperbaric oxygen therapy. Laryngoscope 2012;122:1154–7. 20. Hart GB, Strauss MB. Gender differences in human skeletal mus- cle and subcutaneous tissue gases under ambient and hyperbaric oxygen conditions. Undersea Hyperb Med 2007;34:147–61.